Curaleaf Holdings, Inc. - CEO, Joseph Lusardi
CEO, Joseph Lusardi
Source: The Boston Globe
  • Curaleaf Holdings (CSE:CURA) has received Essential Services Designation to continue operating in key markets despite the COVID-19 crisis
  • The designation has also been offered to basic goods providers like grocery stores and pharmacies
  • The company has adjusted its operating hours to cater for increased demand, as well as the prioritization of vulnerable customers
  • Greater social distancing, sanitation and hygiene measures have also implemented at its outlets
  • Curaleaf Holdings (CURA) is currently up 7.37 per cent to C$4.81 per share, with a market cap of $2.28 billion

Curaleaf Holdings (CSE:CURA) has received Essential Services Designation to continue operating in key markets despite the COVID-19 crisis.

Businesses that have received the designation include all vital healthcare operations. This extends to research and laboratory services, key infrastructure, utilities, mail and shipping services, grocery stores and pharmacies.

However, the opportunity to continue with the provision of these services is dependent on the implementation of strict new policies.

As such, Curaleaf has said that it will enforce social distancing, increase sanitization and hygiene requirements, and use technology to reduce the extent of human to human contact.

Joseph Lusardi, CEO of Curaleaf Holdings, said that the company is responding as quickly as possible to ensure its continued service to customers in need.

“We have never been more committed to providing our vital services and products and will continue to do everything we can to fulfill that mission while protecting the wellbeing of our dedicated employees.

“In these difficult times, we will be hiring employees and working with local organizations to provide job opportunities to those who are out of work,” he added.

Curaleaf’s dispensaries in Arizona, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon will remain open. However, some of these outlets will be restricted to either medical supply or delivery only.

Operating times at these locations will be adjusted to field the increase in demand. Curaleaf has said that it will also prioritize the needs of vulnerable patients, such as senior citizens and those with existing health conditions.

Curaleaf Holdings (CURA) is currently up 7.37 per cent to C$4.81 per share at 9:32am EST.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.